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Abstract
BACKGROUND—Birth defects affect 3% of babies born, and are one of the leading causes of 
infant mortality. Both younger and older maternal age may pose increased risks for certain birth 
defects. This study assessed the relationship between maternal age at the estimated delivery date 
and the risk for birth defects.
METHODS—Data were obtained from the National Birth Defects Prevention Study, a 
population-based case-control study including mothers across 10 states. Maternal age was 
stratified into six categories: <20, 20 to 24, 25 to 29, 30 to 34, 35 to 39, and ≥40 years, and also 
analyzed as a continuous variable. Logistic regression models adjusted for maternal race/ethnicity, 
education, body mass index (BMI), folic acid use, smoking, gravidity, and parental age difference 
were used to estimate adjusted odds ratios (aORs) and 95% confidence intervals (CIs).
RESULTS—For maternal age <20 years, associations with total anomalous pulmonary venous 
return (aOR, 2.3; 95% CI, 1.3–4.0), amniotic band sequence (aOR, 2.4; 95% CI, 1.5–3.8), and 
gastroschisis (aOR, 6.1; 95% CI, 4.8–8.0) were observed. For the ≥40 year age group, associations 
with several cardiac defects, esophageal atresia (aOR, 2.9; 95% CI, 1.7–4.9), hypospadias (aOR, 
2.0; 95% CI, 1.4–3.0), and craniosynostosis (aOR, 1.6; 95% CI, 1.1–2.4) were observed. Results 
using maternal age as a continuous variable were consistent with those that used categorized 
maternal age.
CONCLUSION—Elucidating risk factors specific to women at either extreme of maternal age 
may offer prevention opportunities. All women should be made aware of prevention opportunities, 
such as folic acid supplementation, to reduce the occurrence of birth defects.
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INTRODUCTION
Although birth defects affect 3% of births, causes are not known for about two-thirds of 
cases (Nelson and Holmes, 1989; Brent, 1999; Canfield et al., 2006; Centers for Disease 
Control and Prevention, 2008). Both younger and older maternal age may pose increased 
risks for birth defects (Reefhuis and Honein, 2004; Loane et al., 2009), and these risks are of 
significant public health importance as the birth rate in the United States to women aged 15 
to 19 years is 39.1 births per 1000 teenagers, and 10.1 births per 1000 women aged 40 to 44 
years (Centers for Disease Control and Prevention, 2011).
Young Maternal Age
Births to teenage mothers have decreased in recent years in the United States, but still 
accounted for 6.4% of annual live births in 2009 (National Center for Health Statistics, 
2010). This proportion is one of the highest among industrialized countries (Centers for 
Disease Control and Prevention, 2011), and represents a tremendous ongoing socioeconomic 
cost as numerous studies have determined that teenage pregnancies are susceptible to 
adverse pregnancy outcomes including intrauterine growth restriction, low birthweight, and 
preterm delivery (Chandra et al., 2002; Khashan et al., 2010). Limited data, however, exist 
on the associations between young maternal age and birth defects. In a retrospective cohort 
study conducted in the United States, strong associations between younger maternal age, 13 
to 19 years, and certain birth defects in the offspring were identified, including 
malformations of the central nervous system, gastrointestinal tract, and musculoskeletal 
system (Chen et al., 2007). More consistent results have been published with respect to the 
association between young maternal age and gastroschisis (Reefhuis and Honein, 2004; 
Loane et al., 2009; Benjamin et al., 2010; Chabra et al., 2011). A recently published study 
based on data from 15 European countries observed associations between teenage 
pregnancies and gastroschisis, tricuspid atresia, anencephaly, and defects of the 
gastrointestinal and nervous systems (Loane et al., 2009). Interestingly, the maternal age 
pattern of risk for birth defects differed among European countries, suggesting that lifestyle 
factors or genetic background, rather than biologic age, contribute to the etiology for birth 
defects in younger mothers (Loane et al., 2009). Other studies have hypothesized that 
adverse pregnancy outcomes in younger mothers can be attributed to nonbiologic factors 
such as lower socioeconomic status, predictive lack of health insurance and appropriate 
prenatal care, including supplementation with folic acid-containing multivitamins 
(Reichman and Pagnini, 1997; Nilsen et al., 2006; Raatikainen et al., 2006; Wahn and 
Nissen, 2008).
Older Maternal Age
Older maternal age is associated with risks such as problems with fertility, multiple births, 
and chromosomal anomalies; however, more women are delaying childbearing (American 
Society for Reproductive Medicine, 2003; Tough et al., 2007), resulting in 14.9% of annual 
live births occurring in women aged 35 years or older (National Center for Health Statistics, 
2010). It is widely recognized that older maternal age is strongly associated with 
chromosomal birth defects such as trisomies 13, 18, and 21 (Hagen et al., 2011). Several 
studies have also observed an association between older maternal age and nonchromosomal 
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birth defects such as neural tube defects, cleft lip or palate, congenital inguinal hernia, and 
cardiac defects (Baird et al., 1991; Czeizel, 1988; Khoshnood et al., 2008; Reefhuis and 
Honein, 2004). It has been proposed that the risk for nonchromosomal birth defects with 
older maternal age is negligible compared to the risk for chromosomal birth defects (Loane 
et al., 2009); however, the magnitude of risk for specific nonchromosomal defects is still 
unclear.
Rationale
Although a plethora of data exist regarding increased risks for chromosomal birth defects, 
debate still lingers over whether older maternal age increases the risk for nonchromosomal 
birth defects (Loane et al., 2009; Materna–Kiryluk et al., 2009). Similarly, limited data exist 
on the effects of younger maternal age on the potential for increased risks for birth defects. 
In a previous study conducted by Reefhuis and Honein, 2004, age-related increases in 
specific birth defects were observed. Data from that study, however, were collected between 
1968 and 2000 from a single geographic region in the United States (the Metropolitan 
Atlanta Congenital Defects Program), and may not be representative of the United States 
(Reefhuis and Honein, 2004). Although certain risk factors, such as maternal race, were 
controlled for in that previous study, other risk factors, such as body mass index (BMI), 
were not included in the adjusted models (Reefhuis and Honein, 2004). An increase in 
public health awareness initiatives regarding smoking and alcohol use during pregnancy, 
prenatal care, and supplementation with folic acid-containing multivitamins may have also 
contributed to a potential reduction in these age-associated risk factors for certain birth 
defects since the time those data were published (Rasmussen et al., 2009). The objective of 
this study was to use more current data obtained across the United States to assess the 
association between maternal age and the risk for birth defects of unknown etiology.
METHODS
Design and Study Population
The National Birth Defects Prevention Study (NBDPS) is a population-based, case-control 
study that includes case infants identified through either statewide or regional birth defect 
surveillance systems in Arkansas, California, Georgia, Iowa, Massachusetts, New Jersey, 
New York, North Carolina, Texas, and Utah. The study is described in detail elsewhere 
(Yoon et al., 2001).
Case infants include live born infants (all sites), fetal deaths, defined as ≥20 weeks gestation 
(all sites except New Jersey and New York before January 2000), and pregnancy 
terminations at any gestational age (all sites except Massachusetts, New Jersey, and New 
York before January 2000) with at least one of more than 30 types of major structural birth 
defects. Infants with recognized or strongly suspected chromosomal abnormalities or single-
gene disorders are excluded from the NBDPS. To ensure the infant's birth defect meets the 
NBDPS case definition, experts in clinical genetics or pediatric cardiology review case 
records. Details of the clinical methods of the study have been published elsewhere 
(Rasmussen et al., 2003). Control infants include live born infants with no major birth 
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defects randomly selected from birth certificates or birth hospitals from the same source 
population and time period as case infants.
Mothers of any age, with the exception of those residing in New York (minimum maternal 
age of 18 years from 2004–2008), and Georgia and Iowa (minimum maternal age of 18 
years for all study years) are contacted 6 weeks to 24 months after their estimated delivery 
date (EDD). Of eligible case and control mothers, 70% and 69% agreed to participate, 
respectively. After obtaining informed consent, a trained interviewer administers a 
standardized computer-assisted telephone interview in English or Spanish to ascertain 
exposures and behaviors 3 months before and during pregnancy, and to obtain information 
on maternal and paternal demographic and lifestyle factors and pregnancy history. The 
NBDPS is approved by the institutional review boards of participating study sites and the 
Centers for Disease Control and Prevention.
This analysis was limited to mothers who completed the interview and had an EDD from 
October 1, 1997, through December 31, 2007. Infants whose mothers reported having type 1 
or type 2 diabetes were excluded because of the strong association between diabetes and 
birth defects (Verheijen et al., 2005). Only singleton pregnancies were included in the 
analyses as an association between birth defects and multiple pregnancies has been observed 
(Li et al., 2003, Zhang et al., 2011).
Maternal age at EDD was calculated from self-reported maternal birth date and date of the 
last menstrual period. To retain consistency and allow for comparisons with published 
literature, maternal age at EDD was categorized as follows: <20, 20 to 24, 25 to 29, 30 to 34, 
35 to 39, and ≥40 years. Analyses were performed for birth defect categories containing 100 
or more case infants in total, and three or more case infants per age category to avoid 
assessments with insufficient statistical power.
Statistical Analyses and Covariates
Univariate analyses were conducted using Pearson chi-square tests to estimate crude odds 
ratios (cORs) and 95% confidence intervals (CIs) relative to the 25 to 29 year age group for 
each birth defect. For cells with expected counts less than five, the Fisher exact test was 
used to calculate the cOR and 95% CI.
Separate multivariate logistic regression models for each birth defect were used to estimate 
maternal age-specific adjusted odds ratios (aORs) and 95% CIs relative to the 25 to 29 year 
age group. A priori selected covariates included in the models were maternal race/ethnicity 
(non-Hispanic white, non-Hispanic black, Hispanic, all other races and ethnicities), maternal 
education (<12 years, ≥12 years), maternal BMI (<18.5 kg/m2, 18.5–24.9 kg/m2, ≥25 
kg/m2), maternal periconceptional folic acid use during the month before pregnancy to the 
end of the first trimester (no use, at least some use in each of the months from the month 
before pregnancy to the end of the first trimester, at least some use from the month before 
pregnancy to the end of the first trimester), gravidity (1, >1), maternal periconceptional 
smoking (yes, no), and parental age difference (0–5 years, father >5 years older, mother >5 
years older).
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Exploratory data analysis was conducted for each birth defect by dividing maternal age at 
EDD into quartiles, and determining the proportion of birth defect cases in each quartile. 
Based on the results from this exploratory data analysis, most birth defects examined 
suggested a linear or flat relationship with maternal age, with the exception of gastroschisis 
and perimembranous ventricular septal defect, both of which exhibited a quadratic 
relationship with maternal age. Maternal age at EDD was used as a linear, continuous 
variable in separate multivariate regression models using the same covariates listed above 
for each birth defect to estimate aORs and 95% CIs for each additional year of maternal age. 
For gastroschisis and perimembranous ventricular septal defect, maternal age at EDD was 
also assessed as a quadratic term in multivariable regression models; however, because these 
results were similar to the results when maternal age was used as a linear, continuous 
variable, the results using maternal age as a quadratic term are not presented.
Subanalysis was conducted after excluding for the use of illicit drugs, which is known to be 
more common in younger women, and the use of fertility treatment, which is more common 
in older women and has been shown to be associated with certain birth defects in previous 
studies (Hansen et al., 2005; Zhu et al., 2006; Reefhuis et al., 2009; Reefhuis et al., 2011). A 
single subanalysis was conducted in which mothers were excluded if they reported illicit 
drugs such as marijuana, crack-cocaine, or heroin, or fertility treatments such as 
introcytoplasmic sperm injection, in vitro fertilization, or fertility drugs such as clomiphene 
citrate. Because the number of women exposed to illicit drugs or fertility treatments was 
small, the subanalysis excluded women exposed to any of these substances.
All statistical analyses were performed using SAS 9.2 (SAS Institute, Cary, NC).
RESULTS
In total, the NBDPS contains interviews from mothers of 23,333 case infants and 8494 
control infants for 1997 to 2007. After applying the exclusion criteria, the final analytical 
sample size consisted of 20,377 case infants and 8169 control infants (Fig. 1).
The mean maternal age at EDD for case mothers and control mothers was the same at 27.5 
years. The median maternal age at EDD was also the same for case mothers and control 
mothers at 27 years. For case mothers, the maternal age range was 12 to 53 years; for control 
mothers, the maternal age range was 13 to 50 years.
Case and control mothers were demographically similar within each age category (data not 
shown). Table 1 shows the characteristics of control mothers by age category. As maternal 
age increased, the proportion of non-Hispanic white mothers increased; conversely, as age 
increased, the proportion of Hispanic and non-Hispanic black mothers decreased (Table 1). 
The proportion of smokers was 2.5 times higher in mothers <20 years compared to mothers 
≥40 years of age; alternatively, the use of folic acid-containing supplements increased with 
increasing maternal age (Table 1). As age increased, there were a greater proportion of 
women with at least a high school education, and with more than one previous pregnancy 
(Table 1).
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Of 60 birth defect categories considered for these analyses, 51 defects had at least 100 cases; 
of these 51 defects, 8 defects had <3 case infants in the ≥40 years age category. The cORs, 
aORs, and 95% CIs were calculated; because there were minimal differences between the 
cORs and the aORs, only the aORs are presented.
We assessed the association between all birth defects categories and maternal age categories, 
adjusted for potential confounders (Table 2). For maternal age <20 years, positive 
associations with total anomalous pulmonary venous return (aOR, 2.3; 95% CI, 1.3–4.0), 
amniotic band sequence (aOR, 2.4; 95% CI, 1.5–3.8), and gastroschisis (aOR, 6.1; 95% CI, 
4.8–8.0) were observed.
For the ≥40 years age group, positive associations with several cardiac defects were 
observed including Tetralogy of Fallot (aOR, 2.2; 95% CI, 1.4–3.3), perimembranous 
ventricular septal defect (aOR, 2.5; 95% CI, 1.8–3.5), atrial septal defect, not otherwise 
specified (aOR, 2.5; 95% CI, 1.5–4.1), and ventricular septal defect + atrial septal defect 
association (aOR, 2.9; 95% CI, 1.8–4.7). Non-cardiac defects observed to be associated with 
maternal age ≥40 years were esophageal atresia (aOR, 2.9; 95% CI, 1.7–4.9), hypospadias 
(aOR, 2.0; 95% CI, 1.4–3.0), and craniosynostosis (aOR, 1.6; 95% CI, 1.1–2.4).
Interestingly, for the <20 years age category, there were a few birth defects associated with 
reduced aORs including cataracts and lens defects (aOR, 0.5; 95% CI, 0.3–0.9), 
perimembranous ventricular septal defect (aOR, 0.7; 95% CI, 0.6–0.9), left ventricular 
outflow tract obstruction (aOR, 0.6; 95% CI, 0.5–0.8), coarctation of the aorta (aOR, 0.5; 
95% CI, 0.4–0.8), hypospadias (aOR, 0.6; 95% CI, 0.5–0.8), and craniosynostosis (aOR, 
0.6; 95% CI, 0.4–0.8). In comparison, the only birth defect with a reduced aOR observed 
with increasing maternal age was gastroschisis; for the 30 to 34 and 35 to 39 age categories, 
the aORs were 0.5 (95% CI, 0.3–0.6) and 0.2 (95% CI, 0.1–0.3), respectively, and no cases 
of gastroschisis were present in the ≥40 years age category.
When maternal age at EDD was used as a linear, continuous variable in the regression 
models, the results were consistent with those findings that used categorized maternal age 
(Table 3). Notably, however, the aORs for cleft palate (aOR, 1.04; 95% CI, 1.02–1.06) and 
duodenal atresia/stenosis (aOR, 1.05; 95% CI, 1.01–1.08) were observed to be significant. 
Some defects that showed associations for some age categories, such as total anomalous 
pulmonary venous return did not show a linear association; this could reflect a more u-
shaped association.
After excluding for illicit drug use in both case (n = 365) and control (n = 143) mothers, and 
the use of fertility treatments in case (n = 1005) and control (n = 239) mothers, there were 
no substantial differences in the aORs for any specific birth defect as presented in Table 2.
DISCUSSION
Based on these findings, in the United States, younger maternal age, <20 years, is associated 
with gastroschisis, amniotic band sequence, and, perhaps, anomalous pulmonary venous 
return. On the other hand, older maternal age, ≥40 years, is associated with some atrial and 
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ventricular septal defects, Tetralogy of Fallot, esophageal atresia, craniosynostosis, and 
hypospadias.
Previous studies have also observed increased risks for gastroschisis with younger maternal 
age (Loane et al., 2009; Benjamin et al., 2010; Chabra et al., 2011). The increased risk for 
gastroschisis observed in the younger population has been hypothesized to be caused by risk 
factors disproportionately higher among adolescents (Rasmussen and Frias, 2008). These 
risk factors include low BMI, cigarette smoking, use of illicit drugs, genitourinary 
infections, sexually transmitted diseases, and Epstein–Barr virus (Loane et al., 2009; Werler, 
2010). The increased risk for gastroschisis in younger mothers observed in this study is 
possibly associated with cigarette smoking because we observed higher proportions of teen 
mothers self-reporting smoking compared with older mothers (Table 2); however, in an 
earlier analysis of a subset of this data, cigarette smoking was not associated with young 
maternal age (Mac Bird et al., 2009, Werler et al., 2009).
Similar to the present findings, several studies have observed an association between 
amniotic band sequence and young maternal age (Garza et al., 1988; Mastroiacovo et al., 
1992; Bower et al., 1993). A case-control study using data from Boston, Philadelphia, and 
Toronto observed a threefold increase in amniotic band sequence in mothers <25 years of 
age; however, this association was not found to be statistically significant (Werler et al., 
2003). Interestingly, etiologic theories for both gastroschisis and amniotic band sequence 
include vascular disruptions, immune system involvement, or poor nutritional status 
associated with younger maternal age (Martínez–Frías et al., 2000; Werler et al., 2003; 
Rasmussen and Frias, 2008). This study could not assess these risk factors; however, a 
greater proportion of teenage mothers in the present study were underweight with a BMI of 
<18.5 kg/m2 compared with older mothers, suggesting nutritional deficiencies may exist in 
this younger group (Table 2).
For total anomalous pulmonary venous return, we observed a statistically significant 
increased odds ratio for young maternal age, and although the odds ratio for older maternal 
age was elevated, it was not found to be statistically significant. A study using NBDPS data 
from 1997 through 2004 observed associations with young and old paternal age and 
anomalous pulmonary venous return; however, only the associations with young paternal 
age were observed to be statistically significant (Green et al., 2010). Loane et al. (2009) also 
observed elevated odds ratios for young and older maternal age pointing toward a possible 
u-shaped association with maternal age. However, when maternal age was used either as a 
linear or quadratic continuous variable in the regression models, this association was not 
observed.
Several studies propose that the association between young maternal age and poor 
pregnancy outcome, including birth defects, is related to biologic factors such as mother's 
gynecological immaturity and nutritional status (Scholl et al., 1990; Wallace et al., 2001; 
Raatikainen et al., 2006). Fetal growth and development is highly dependent on placental 
growth and transport of nutrients; in adolescent pregnancies, competition for nutrients 
between the developing adolescent and the placenta and fetus may result in adverse 
pregnancy outcomes (Wallace et al., 2001). Additionally, teenage mothers are more likely to 
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smoke, drink alcohol, and have poor diet resulting in greater nutritional deficits (Scholl et 
al., 1990; Raatikainen et al., 2006; Wahn and Nissen, 2008) compared with older mothers.
Compared to young maternal age, results from this study suggest that older maternal age 
may be a stronger risk factor for certain cardiac defects. Specifically, in mothers ≥40 years, 
increased risks for several cardiac defects were observed including ventricular septal 
defects, atrial septal defects, and Tetralogy of Fallot. Several other studies have observed an 
association between older maternal age and the risk for cardiac defects (Reefhuis and 
Honein, 2004; Reller et al., 2008; Materna–Kiryluk et al., 2009). A more recent study using 
data from the Metropolitan Atlanta Congenital Defects Program (one of the 10 birth defects 
surveillance systems contributing cases to the NBDPS) assessed the association between 
maternal age and the risk for isolated cardiac defects that excluded defects with syndromes; 
results from this study showed associations between maternal age ≥35 years and conotruncal 
defects, coarctation of the aorta, ventricular septal defects, and atrial septal defects (Miller et 
al., 2011). It is important to point out, however, that maternal age ≥35 years is a common 
reason for referral for fetal echocardiography, which can detect cardiac defects more reliably 
than a regular ultrasound (Davey et al., 2009). Because ventricular septal defects may close 
spontaneously up to 2 years after birth (Helgason and Jonsdottir, 1999; Mehta et al., 2000), 
it is possible that these defects are not detected if they occur and spontaneously close in 
infants born to younger mothers.
Consistent with previous research using data from the United States, we observed 
associations between older maternal age and noncardiac defects such as hypospadias 
(Reefhuis and Honein, 2004). A study using NBDPS data from 1997 to 2000 observed an 
association between maternal age ≥35 years and hypospadias (Carmichael et al., 2007). 
However, two studies using data from Europe did not observe an association between 
maternal age and hypospadias (Loane et al., 2009; Materna–Kiryluk et al., 2009). 
Hypospadias is the most common major genital birth defect among male infants, and 
although research is being conducted to identify the cause, the etiology is still unknown but 
it is thought to be multifactorial, with genetic and environmental factors playing a role 
(Kalfa et al., 2009; Kalfa et al., 2010).
Results from this study suggest an association between older maternal age and esophageal 
atresia. A study conducted using data from 1998 to 2002 from the Polish Registry of 
Congenital Malformations observed an elevated, but nonstatistically significant, odds ratio 
between esophageal atresia and maternal age (Materna–Kiryluk et al., 2009), and results 
from a large European study including 15 countries also observed an increased risk for 
esophageal atresia in older mothers (Loane et al., 2009). Loane et al. (2009) did not observe 
an increased risk for craniosynostosis in older mothers; whereas, results from the present 
study showed a twofold increased risk for craniosynostosis in older mothers consistent with 
previously published US data (Reefhuis and Honein, 2004). It is possible that certain risk 
factors may differ among countries and contribute more heavily to the susceptibility of 
certain birth defects; however, differences in study design, case definition, and potential 
confounders may play a role in the discrepancies observed.
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In older mothers, biologic factors such as ovarian age are thought to contribute more to 
adverse pregnancy outcomes than nonbiologic factors (Raatikainen et al., 2006). Ovarian 
follicles established during fetal life exponentially decline in quantity and quality over the 
years, resulting in subfertility as early as 30 years of age (te Velde et al., 1998). In addition 
to decreased ova quality, age-related increases in comorbidities, such as hypertension and 
gestational diabetes, contribute to increased risks for pregnancy complications, and possibly 
birth defects (Raatikainen et al., 2006; Khoshnood et al., 2008; Schoen and Rosen, 2009; 
Yogev et al., 2010).
Compared to previous work, this study has several key strengths. Results from the data 
analysis were consistent when maternal age was either categorized or used as a continuous 
variable. Furthermore, data on demographics and risk factors such as BMI, smoking, and 
folic acid use are collected and have been incorporated into the logistic regression models; 
whereas, in other studies, these variables are not always available and accounted for in the 
analysis. Additionally, women with certain risk factors that have been consistently 
associated with birth defects, such as type 1 and type 2 diabetes and multiple pregnancies, 
were excluded from this analysis. Although the aforementioned data are based on self-
report, the exposure of interest, maternal age calculated by date of birth, is unlikely to be 
affected by recall bias or misreported. Furthermore, misclassification of birth defect 
outcomes was minimized by case records being reviewed by experts in medical genetics or 
pediatric cardiology based on specific standardized inclusion criteria for each defect.
Results from this study are based on data collected from control mothers from the same 
source population and time period as case mothers, and have been shown to be 
representative of mothers across the United States (Cogswell et al., 2009). An important 
limitation; however, is that Iowa, Georgia, and New York (for some years) did not include 
mothers <18 years of age. The large sample size allows for the evaluation of individual birth 
defects with sufficient statistical power; however, the multiple testing conducted in this 
analysis may be responsible for some of the positive associations observed. Furthermore, 
this study did not assess the association between maternal age and isolated defects; all 
analyses conducted included both isolated and multiple defects. This study was not designed 
to assess the association between environmental risk factors specific to younger versus older 
mothers, although based on the exclusion criteria, in this analysis, preexisting diabetes and 
multiple births can be excluded as contributing to this etiologic pathway. Despite the 
aforementioned limitations, results obtained from these data can assist in making public 
health recommendations to help reduce the occurrence of specific birth defects that may be 
associated with certain risk factors in older or younger mothers.
The rate of live births among teenagers in the United States is one of the highest among 
industrialized countries, and this study shows that birth defects among teen-age mothers are 
a public health concern. Similarly, rates of live births among older mothers are increasing, 
and although there may be associations between biologic factors and certain birth defects 
that cannot be modified, modifications in lifestyle factors can help to improve infant 
outcomes. Regardless of age, women who optimize their health before conception, and are 
aware of information on all risks and potential prevention opportunities, such as smoking 
cessation and supplementation with folic acid, can reduce their risks for birth defects.
Gill et al. Page 9
Birth Defects Res A Clin Mol Teratol. Author manuscript; available in PMC 2015 August 11.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Acknowledgments
Funding: This work was supported through cooperative agreements under PA 96043, PA 02081, and FOA 
DD09-001 from the Centers for Disease Control and Prevention to the Centers for Birth Defects Research and 
Prevention participating in the National Birth Defects Prevention Study.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official 
position of the Centers for Disease Control and Prevention.
REFERENCES
American Society for Reproductive Medicine (ASRM). Age and fertility: a guide for patients. 2003. 
Baird PA, Sadovnick AD, Yee IM. Maternal age and birth defects: a population study. Lancet. 1991; 
337:527–530. [PubMed: 1671898] 
Benjamin BG, Ethen MK, Van Hook CL, et al. Gastroschisis prevalence in Texas 1999–2003. Birth 
Defects Res A Clin Mol Teratol. 2010; 88:178–185. [PubMed: 19950387] 
Bower C, Norwood F, Knowles S, et al. Amniotic band syndrome: a population-based study in two 
Australian states. Paediatr Perinat Epidemiol. 1993; 7:395–403. [PubMed: 8290379] 
Brent RL. Utilization of developmental basic science principles in the evaluation of reproductive risks 
from pre- and postconception environmental radiation exposures. Teratology. 1999; 59:182–204. 
[PubMed: 10331519] 
Canfield MA, Honein MA, Yuskiv N, et al. National estimates and race/ethnic-specific variation of 
selected birth defects in the United States, 1999–2001. Birth Defects Res A Clin Mol Teratol. 2006; 
76:747–756. [PubMed: 17051527] 
Carmichael SL, Shaw GM, Laurent C, et al. Maternal reproductive and demographic characteristics as 
risk factors for hypospadias. Paediatr Perinat Epidemiol. 2007; 21:210–218. [PubMed: 17439529] 
Centers for Disease Control and Prevention (CDC). Update on overall prevalence of major birth 
defects–Atlanta, Georgia, 1978–2005. MMWR Morb Mortal Wkly Rep. 2008; 57:1–5. [PubMed: 
18185492] 
Centers for Disease Control and Prevention (CDC). Vital signs: teen pregnancy–United States, 1991–
2009. MMWR Morb Mortal Wkly Rep. 2011; 60:414–420. [PubMed: 21471949] 
Chabra S, Gleason CA, Seidel K, Williams MA. Rising prevalence of gastroschisis in Washington 
State. J Toxicol Environ Health A. 2011; 74:336–345. [PubMed: 21240733] 
Chandra PC, Schiavello HJ, Ravi B, et al. Pregnancy outcomes in urban teenagers. Int J Gynaecol 
Obstet. 2002; 79:117–122. [PubMed: 12427395] 
Chen XK, Wen SW, Fleming N, et al. Teenage pregnancy and congenital anomalies: which system is 
vulnerable? Hum Reprod. 2007; 22:1730–1735. [PubMed: 17371802] 
Cogswell ME, Bitsko RH, Anderka M, et al. Control selection and participation in an ongoing, 
population-based, case-control study of birth defects: the National Birth Defects Prevention Study. 
Am J Epidemiol. 2009; 170:975–985. [PubMed: 19736223] 
Czeizel A. Maternal mortality, fetal death, congenital anomalies and infant mortality at an advanced 
maternal age. Maturitas Suppl. 1988; 1:73–81.
Davey BT, Seubert DE, Phoon CK. Indications for fetal echocardiography high referral, low yield? 
Obstet Gynecol Surv. 2009; 64:405–415. [PubMed: 19445814] 
Garza A, Cordero JF, Mulinare J. Epidemiology of the early amnion rupture spectrum of defects. Am J 
Dis Child. 1988; 142:541–544. [PubMed: 3358397] 
Green RF, Devine O, Crider KS, et al. Association of paternal age and risk for major congenital 
anomalies from the National Birth Defects Prevention Study, 1997 to 2004. Ann Epidemiol. 2010; 
20:241–249. [PubMed: 20056435] 
Hagen A, Entezami M, Gasiorek–Wiens A, et al. The impact of first trimester screening and early fetal 
anomaly scan on invasive testing rates in women with advanced maternal age. Ultraschall Med. 
2011; 32:302–306. [PubMed: 20972947] 
Hansen M, Bower C, Milne E, et al. Assisted reproductive technologies and the risk of birth defects–a 
systematic review. Hum Reprod. 2005; 20:328–338. [PubMed: 15567881] 
Gill et al. Page 10
Birth Defects Res A Clin Mol Teratol. Author manuscript; available in PMC 2015 August 11.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Helgason H, Jonsdottir G. Spontaneous closure of atrial septal defects. Pediatr Cardiol. 1999; 20:195–
199. [PubMed: 10089243] 
Kalfa N, Philibert P, Sultan C. Is hypospadias a genetic, endocrine or environmental disease, or still an 
unexplained malformation? Int J Androl. 2009; 32:187–197. [PubMed: 18637150] 
Kalfa N, Sultan C, Baskin LS. Hypospadias: etiology and current research. Urol Clin North Am. 2010; 
37:159–166. [PubMed: 20569795] 
Khashan AS, Baker PN, Kenny LC. Preterm birth and reduced birth-weight in first and second teenage 
pregnancies: a register-based cohort study. BMC Pregnancy Childbirth. 2010; 10:36. [PubMed: 
20618921] 
Khoshnood B, Bouvier–Colle MH, Leridon H, Blondel B. Impact of advanced maternal age on 
fecundity and women's and children's health. [Article in French] J Gynecol Obstet Biol Reprod 
(Paris). 2008; 37:733–747. [PubMed: 18929450] 
Li SJ, Ford N, Meister K, Bodurtha J. Increased risk of birth defects among children from multiple 
births. Birth Defects Res A Clin Mol Teratol. 2003; 67:879–885. [PubMed: 14745942] 
Loane M, Dolk H, Morris JK, EUROCAT Working Group. Maternal age-specific risk of non-
chromosomal anomalies. BJOG. 2009; 116:1111–1119. [PubMed: 19485989] 
Mac Bird T, Robbins JM, Druschel C, et al. Demographic and environmental risk factors for 
gastroschisis and omphalocele in the National Birth Defects Prevention Study. J Pediatr Surg. 
2009; 44:1546–1551. [PubMed: 19635303] 
Martínez–Frías ML, Bermejo E, Rodríguez–Pinilla E. Body stalk defects, body wall defects, amniotic 
bands with and without body wall defects, and gastroschisis: comparative epidemiology. Am J 
Med Genet. 2000; 92:13–18. [PubMed: 10797417] 
Mastroiacovo P, Källén B, Knudsen LB, et al. Absence of limbs and gross body wall defects: an 
epidemiological study of related rare malformation conditions. Teratology. 1992; 46:455–464. 
[PubMed: 1462250] 
Materna–Kiryluk A, Wiśniewska K, Badura–Stronka M, et al. Parental age as a risk factor for isolated 
congenital malformations in a Polish population. Paediatr Perinat Epidemiol. 2009; 23:29–40. 
[PubMed: 19228312] 
Mehta AV, Goenka S, Chidambaram B, Hamati F. Natural history of isolated ventricular septal defect 
in the first five years of life. Tenn Med. 2000; 93:136–138. [PubMed: 10754804] 
Miller A, Riehle–Colarusso T, Siffel C, et al. Maternal age and prevalence of isolated congenital heart 
defects in an urban area of the United States. Am J Med Genet A. 2011; 155A:2137–2145. 
[PubMed: 21815253] 
National Center for Health Statistics. Births: Preliminary Data for 2009. 2010. National Vital Statistics 
Report. 
Nelson K, Holmes LB. Malformations due to presumed spontaneous mutations in newborn infants. N 
Eng J Med. 1989; 320:19–23.
Nilsen RM, Vollset SE, Gjessing HK, et al. Patterns and predictors of folic acid supplement use among 
pregnant women: the Norwegian Mother and Child Cohort Study. Am J Clin Nutr. 2006; 84:1134–
1141. [PubMed: 17093167] 
Raatikainen K, Heiskanen N, Verkasalo PK, Heinonen S. Good outcome of teenage pregnancies in 
high-quality maternity care. Eur J Public Health. 2006; 16:157–161. [PubMed: 16141302] 
Rasmussen SA, Erickson JD, Reef SE, Ross DS. Teratology: from science to birth defects prevention. 
Birth Defects Res A Clin Mol Teratol. 2009; 85:82–92. [PubMed: 19067401] 
Rasmussen SA, Frías JL. Non-genetic risk factors for gastroschisis. Am J Med Genet C Semin Med 
Genet. 2008; 148C:199–212. [PubMed: 18655102] 
Rasmussen SA, Olney RS, Holmes LB, et al. Guidelines for case classification for the National Birth 
Defects Prevention Study. Birth Defects Res A Clin Mol Teratol. 2003; 67:193–201. [PubMed: 
12797461] 
Reefhuis J, Honein MA. Maternal age and non-chromosomal birth defects, Atlanta–1968–2000: 
teenager or thirty-something, who is at risk? Birth Defects Res A Clin Mol Teratol. 2004; 70:572–
579. [PubMed: 15368555] 
Reefhuis J, Honein MA, Schieve LA, et al. Assisted reproductive technology and major structural birth 
defects in the United States. Hum Reprod. 2009; 24:360–366. [PubMed: 19010807] 
Gill et al. Page 11
Birth Defects Res A Clin Mol Teratol. Author manuscript; available in PMC 2015 August 11.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Reefhuis J, Honein MA, Schieve LA, et al. Use of clomiphene citrate and birth defects, National Birth 
Defects Prevention Study, 1997–2005. Hum Reprod. 2011; 26:451–457. [PubMed: 21112952] 
Reichman NE, Pagnini DL. Maternal age and birth outcomes: data from New Jersey. Fam Plann 
Perspect. 1997; 29:268–272. [PubMed: 9429872] 
Reller MD, Strickland MJ, Riehle–Colarusso T, et al. Prevalence of congenital heart defects in 
metropolitan Atlanta, 1998–2005. J Pediatr. 2008; 153:807–813. [PubMed: 18657826] 
Schoen C, Rosen T. Maternal and perinatal risks for women over 44–a review. Maturitas. 2009; 
64:109–113. [PubMed: 19822268] 
Scholl TO, Hediger ML, Ances IG. Maternal growth during pregnancy and decreased infant birth 
weight. Am J Clin Nutr. 1990; 51:790–793. [PubMed: 2333837] 
te Velde ER, Scheffer GJ, Dorland M, et al. Developmental and endocrine aspects of normal ovarian 
aging. Mol Cell Endocrinol. 1998; 145:67–73. [PubMed: 9922101] 
Tough S, Benzies K, Fraser–Lee N, Newburn–Cook C. Factors influencing childbearing decisions and 
knowledge of perinatal risks among Canadian men and women. Matern Child Health J. 2007; 
11:189–198. [PubMed: 17237994] 
Verheijen EC, Critchley JA, Whitelaw DC, Tuffnell DJ. Outcomes of pregnancies in women with pre-
existing type 1 or type 2 diabetes, in an ethnically mixed population. BJOG. 2005; 112:1500–
1503. [PubMed: 16225569] 
Wahn EH, Nissen E. Sociodemographic background, lifestyle and psychosocial conditions of Swedish 
teenage mothers and their perception of health and social support during pregnancy and childbirth. 
Scand J Public Health. 2008; 36:415–423. [PubMed: 18539696] 
Wallace J, Bourke D, Da Silva P, Aitken R. Nutrient partitioning during adolescent pregnancy. 
Reproduction. 2001; 122:347–357. [PubMed: 11597301] 
Werler MM. Hypothesis: could Epstein–Barr virus play a role in the development of gastroschisis? 
Birth Defects Res A Clin Mol Teratol. 2010; 88:71–75. [PubMed: 19937602] 
Werler MM, Louik C, Mitchell AA. Epidemiologic analysis of maternal factors and amniotic band 
defects. Birth Defects Res A Clin Mol Teratol. 2003; 67:68–72. [PubMed: 12749386] 
Werler MM, Mitchell AA, Moore CA, et al. Is there epidemiologic evidence to support vascular 
disruption as a pathogenesis of gastroschisis? Am J Med Genet A. 2009; 149A:1399–1406. 
[PubMed: 19533769] 
Yogev Y, Melamed N, Bardin R, et al. Pregnancy outcome at extremely advanced maternal age. Am J 
Obstet Gynecol. 2010; 203:558.e1–558.e7. [PubMed: 20965486] 
Yoon PW, Rasmussen SA, Lynberg MC, et al. The National Birth Defects Prevention Study. Public 
Health Rep. 2001; 116(Suppl 1):32–40. [PubMed: 11889273] 
Zhang XH, Qiu LQ, Huang JP. Risk of birth defects increased in multiple births. Birth Defects Res A 
Clin Mol Teratol. 2011; 91:34–38. [PubMed: 20890935] 
Zhu JL, Basso O, Obel C, et al. Infertility, infertility treatment, and congenital malformations: Danish 
national birth cohort. BMJ. 2006; 333:679. [PubMed: 16893903] 
Gill et al. Page 12
Birth Defects Res A Clin Mol Teratol. Author manuscript; available in PMC 2015 August 11.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 1. 
Flowchart of Included Mothers of Cases and Controls, National Birth Defects Prevention 
Study, 1997 to 2007.
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Table 1
Distribution of a Priori Selected Covariates by Maternal Age Category among Control Mothers, National Birth 
Defects Prevention Study, 1997 to 2007
Maternal Age, Years
Covariatea <20, n (%) 20–24, n (%) 25–29, n (%) 30–34, n (%) 35–39, n (%) ≥40, n (%)
Race/ethnicity n = 861 n = 1911 n = 2151 n = 2025 n = 935 n = 163
 Non-Hispanic white 301 (35) 960 (50) 1231 (59) 1378 (68) 665 (71) 114 (70)
 Non-Hispanic black 158 (18) 265 (14) 219 (10) 160 (8) 78 (8) 15 (9)
 Hispanic 330 (38) 551 (29) 524 (23) 333 (16) 111 (12) 21 (13)
 Other 72 (8) 135 (7) 177 (8) 154 (8) 81 (9) 13 (8)
BMI (kg/m2) n = 816 n = 1796 n = 2154 n = 1966 n = 924 n = 162
 <18.5 90 (11) 136 (8) 89 (4) 76 (4) 27 (3) 7 (4)
 18.5–24.9 497 (61) 919 (51) 1161 (54) 1126 (57) 542 (59) 77 (48)
 ≥25 229 (28) 741 (41) 904 (42) 764 (39) 355 (38) 78 (48)
Folic acid useb n = 858 n = 1902 n = 2242 n = 2028 n = 940 n = 163
 No 251 (29) 387 (20) 316 (14) 208 (10) 100 (11) 19 (12)
 Yesc 55 (6) 284 (15) 709 (32) 829 (41) 421 (45) 82 (38)
 Some used 552 (64) 1231 (65) 1217 (54) 991 (49) 419 (44) 62 (50)
Gravidity n = 862 n = 1907 n = 2249 n = 2029 n = 942 n = 163
 1 602 (70) 687 (36) 614 (27) 367 (18) 104 (11) 17 (10)
 >1 260 (30) 1220 (64) 1635 (73) 1662 (82) 838 (89) 146 (90)
Education, years n = 834 n = 1875 n = 2215 n = 2008 n = 929 n = 163
 <12 447 (54) 414 (22) 276 (13) 177 (9) 63 (7) 11 (7)
 ≥12 387 (46) 1461 (78) 1939 (87) 1831 (91) 866 (93) 152 (93)
Smokinge n = 840 n = 1881 n = 2221 n = 2013 n = 932 n = 163
 No 614 (73) 1362 (72) 1877 (85) 1742 (87) 827 (89) 145 (89)
 Yes 226 (27) 519 (28) 344 (15) 271 (13) 105 (11) 18 (11)
Parental age difference, years n = 865 n = 1913 n = 2254 n = 2032 n = 942 n = 163
 0–5 614 (71) 1408 (73) 1732 (77) 1581 (78) 718 (76) 155 (71)
 Father >5 251 (29) 502 (27) 486 (21) 368 (18) 140 (15) 25 (15)
 Mother >5 0 (0) 3 (<1) 36 (2) 83 (4) 84 (9) 23 (14)
BMI, pre-pregnancy body mass index.
aSome covariates have missing data.
b
Month before pregnancy to the end of the first trimester.
cAt least some use in each of the months from the month before pregnancy to the end of the first trimester.
dAt least some use anytime from the month before pregnancy to the end of the first trimester.
eAnytime during the periconceptional period.
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Table 2
The aORsa and 95% CIs for Birth Defects among Maternal Age Groups, 25 to 29 years Is the Reference, 
National Birth Defects Prevention Study, 1997 to 2007
Birth Defect Cases (Total No.)
aOR (95% CI)
<20 20–24 30–34 35–39 ≥40
Anencephaly and craniorachischisis 377 1.2 (0.8–1.8) 0.9 (0.7–1.3) 0.8 (0.6–1.1) 0.8 (0.6–1.2) 1.5 (0.8–2.7)
Spina bifida 821 1.0 (0.8–1.4) 0.9 (0.7–1.1) 0.7 (0.6–0.9) 0.8 (0.6–1.0) 1.3 (0.9–2.1)
Hydrocephaly 318 1.1 (0.7–1.7) 1.2 (0.8–1.6) 1.0 (0.7–1.4) 0.9 (0.6–1.4) 1.1 (0.5–2.5)
Encephalocele 142 1.3 (0.7–2.1) 1.0 (0.6–1.7) 0.9 (0.6–1.5) 0.9 (0.5–1.7) 2.4 (1.0–5.6)
Holoprosencephaly 100 1.0 (0.5–2.1) 1.2 (0.7–2.1) 1.0 (0.6–1.8) 1.2 (0.6–2.5) Insufficient
Dandy–Walker malformation 105 0.5 (0.4–1.6) 0.8 (0.5–1.5) 1.5 (0.9–2.5) 0.9 (0.4–2.0) Insufficient
Anophthalmos/microphthalmos 151 0.8 (0.4–1.5) 0.8 (0.5–1.3) 0.9 (0.6–1.3) 0.6 (0.3–1.2) 1.3 (0.4–3.6)
Cataracts and other lens defects 232 0.5 (0.3–0.9) 0.7 (0.5–1.1) 0.9 (0.6–1.2) 1.0 (0.6–1.5) 0.9 (0.4–2.4)
Glaucoma and anterior segment defects 117 0.6 (0.2–1.4) 1.4 (0.9–2.4) 1.1 (0.6–1.8) 0.9 (0.5–1.9) 1.3 (0.4–4.3)
Anotia/microtia 404 0.9 (0.6–1.3) 0.9 (0.7–1.3) 1.0 (0.7–1.3) 1.3 (0.9–1.9) 1.0 (0.4–2.2)
Conotruncal defects 1651 0.8 (0.7–1.1) 1.0 (0.8–1.1) 1.2 (1.0–1.4) 1.2 (1.0–1.4) 1.8 (1.3–2.5)
 D-Transposition of the great arteries 526 1.1 (0.8–1.6) 1.1 (0.8–1.4) 1.2 (0.9–1.5) 0.8 (0.6–1.1) 1.6 (1.0–2.7)
 Double outlet right ventricular with 
transposition of the great arteries 101 2.1 (1.0–4.3) 1.0 (0.5–1.8) 1.0 (0.4–1.5) 0.6 (0.9–3.0) Insufficient
Tetralogy of Fallot 750 0.6 (0.4–0.9) 0.9 (0.7–1.2) 1.2 (1.0–1.5) 1.4 (1.1–1.8) 2.2 (1.4–3.3)
Single ventricle/complex heart 218 0.8 (0.5–1.4) 0.7 (0.5–1.1) 0.8 (0.6–1.2) 1.0 (0.7–1.6) 0.8 (0.3–2.3)
Ventricular septal defects, muscular 167 0.8 (0.4–1.7) 0.9 (0.5–1.5) 1.0 (0.6–1.5) 1.0 (0.5–1.7) 1.5 (0.5–5.5)
Ventricular septal defects, 
perimembranous 1293 0.7 (0.6–0.9) 1.0 (0.8–1.2) 1.1 (1.0–1.3) 1.4 (1.1–1.7) 2.5 (1.8–3.5)
Ventricular septal defects, 
conoventricular 101 0.4 (0.2–1.1) 0.7 (0.4–1.2) 1.3 (0.8–2.2) 1.3 (0.6–2.2) 3.1 (1.2–7.8)
Atrial septal defect secundum 1493 0.7 (0.6–0.9) 1.0 (0.8–1.1) 0.9 (0.8–1.1) 0.9 (0.8–1.1) 1.5 (1.0–2.1)
Atrial septal defect, not otherwise 
specified 468 0.8 (0.6–1.2) 0.9 (0.7–1.2) 1.0 (0.7–1.3) 1.1 (0.8–1.5) 2.5 (1.5–4.1)
Ebstein malformation 112 0.7 (0.3–1.6) 1.0 (0.6–1.6) 1.0 (0.6–1.6) 0.8 (0.4–1.7) 2.2 (0.8–5.7)
Right ventricular outflow tract 
obstruction 1258 0.8 (0.6–1.0) 0.9 (0.8–1.1) 1.0 (0.8–1.2) 1.0 (0.8–1.3) 1.5 (1.0–2.2)
 Pulmonary valve stenosis 923 0.8 (0.6–1.0) 0.9 (0.8–1.1) 1.0 (0.8–1.2) 1.0 (0.8–1.3) 1.5 (1.0–2.3)
 Pulmonary atresia 159 1.2 (0.6–2.2) 0.9 (0.6–1.4) 1.0 (0.7–1.6) 0.9 (0.5–1.6) 1.8 (0.7–4.3)
 Tricuspid atresia 106 0.9 (0.4–1.9) 0.9 (0.5–1.5) 0.6 (0.4–1.1) 1.0 (0.5–1.8) 1.0 (0.3–3.6)
Left ventricular outflow tract obstruction 1359 0.6 (0.5–0.8) 0.9 (0.8–1.1) 1.0 (0.9–1.3) 0.8 (0.7–1.1) 1.0 (0.7–1.6)
Coarctation of the aorta 710 0.5 (0.4–0.8) 0.8 (0.7–1.1) 1.2 (1.0–1.5) 0.9 (0.7–1.2) 1.5 (0.9–2.3)
 Aortic stenosis 305 0.6 (0.4–1.1) 0.7 (0.5–1.0) 0.9 (0.7–1.2) 0.9 (0.6–1.4) 0.8 (0.3–1.8)
Hypoplastic left heart syndrome 409 0.9 (0.6–1.4) 1.0 (0.7–1.3) 1.0 (0.8–1.3) 0.8 (0.5–1.1) 1.0 (0.5–1.1)
Total anomalous pulmonary venous 
return 190 2.3 (1.3–4.0) 1.8 (1.2–2.7) 1.2 (0.7–1.8) 1.1 (0.6–2.0) 1.9 (0.8–4.6)
Heterotaxia with CHD 222 1.2 (0.7–1.9) 1.0 (0.7–1.5) 1.1 (0.7–1.6) 1.0 (0.6–1.6) Insufficient
Association: coarctation + ventricular 
septal defect 191 0.4 (0.2–0.8) 1.1 (0.8–1.7) 1.1 (0.8–1.7) 1.0 (0.6–1.7) 1.5 (0.6–3.6)
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Birth Defect Cases (Total No.)
aOR (95% CI)
<20 20–24 30–34 35–39 ≥40
Association: ventricular septal defects + 
atrial septal defects 519 0.7 (0.5–1.1) 0.9 (0.7–1.2) 1.2 (1.0–1.6) 1.3 (1.0–1.8) 2.9 (1.8–4.7)
Association: pulmonary valve stenosis + 
ventricular septal defect 105 1.2 (0.4–2.9) 2.4 (1.3–4.5) 1.9 (1.0–3.6) 2.5 (1.2–5.1) 2.3 (0.5–7.2)
Association: pulmonary valve stenosis + 
atrial septal defect 137 0.6 (0.3–1.1) 0.6 (0.3–0.9) 0.8 (0.5–1.3) 0.9 (0.5–1.7) 1.2 (0.4–3.5)
Cleft lip ± palate 1997 1.0 (0.8–1.2) 1.1 (1.0–1.3) 0.9 (0.8–1.0) 1.0 (0.9–1.2) 1.2 (0.9–1.7)
Cleft palate 1069 0.8 (0.6–1.0) 0.9 (0.8–1.1) 1.0 (0.9–1.2) 1.2 (1.0–1.5) 1.4 (1.0–2.2)
Esophageal atresia 437 1.1 (0.8–1.7) 1.0 (0.7–1.3) 1.4 (1.1–1.9) 1.6 (1.2–2.3) 2.9 (1.7–4.9)
Anorectal atresia/stenosis 661 0.9 (0.6–1.2) 1.2 (0.9–1.5) 1.1 (0.9–1.4) 1.2 (0.9–1.6) 1.1 (0.6–2.0)
Intestinal atresia/stenosis 300 1.1 (0.7–1.6) 0.9 (0.7–1.3) 0.9 (0.6–1.2) 1.4 (0.9–2.1) 1.8 (0.9–3.6)
 Duodenal atresia/stenosis 142 0.7 (0.3–1.4) 1.2 (0.7–1.9) 1.6 (1.0–2.6) 1.6 (0.9–3.0) 2.3 (0.8–6.5)
Biliary atresia 120 1.2 (0.6–2.6) 1.2 (0.7–2.0) 1.2 (0.7–2.0) 0.9 (0.4–1.8) 1.3 (0.4–4.5)
Hypospadias 1466 0.6 (0.5–0.8) 0.9 (0.8–1.1) 1.4 (1.2–1.7) 1.6 (1.3–1.9) 2.0 (1.4–3.0)
Renal agenesis/hypoplasia 106 0.8 (0.4–1.6) 1.0 (0.6–1.6) 0.6 (0.4–1.1) 0.4 (0.2–1.0) Insufficient
Limb deficiency 774 1.2 (0.8–1.5) 1.1 (0.9–1.3) 1.0 (0.8–1.3) 0.8 (0.6–1.1) 1.0 (0.6–1.7)
 Longitudinal preaxial limb deficiency 176 1.1 (0.6–1.9) 1.1 (0.8–1.7) 0.7 (0.5–1.2) 1.0 (0.6–1.8) Insufficient
 Limb deficiency, transverse 459 1.2 (0.8–1.7) 1.1 (0.8–1.4) 1.2 (0.9–1.5) 0.9 (0.6–1.2) 0.7 (0.6–2.5)
Omphalocele 288 0.9 (0.6–1.6) 1.2 (0.9–1.6) 1.0 (0.7–1.4) 1.5 (1.0–2.7) 1.8 (0.9–3.6)
Gastroschisis 899 6.1 (4.8–8.0) 3.1 (2.5–3.9) 0.5 (0.3–0.6) 0.2 (0.1–0.3) Insufficient
Amniotic band syndrome and limb body 
wall complex 219 2.4 (1.5–3.8) 1.7 (1.1–2.5) 0.8 (0.5–1.2) 0.8 (0.4–1.5) Insufficient
Craniosynostosis 966 0.6 (0.4–0.8) 0.8 (0.6–1.0) 1.2 (1.0–1.4) 1.3 (1.1–1.6) 1.6 (1.1–2.4)
Diaphragmatic hernia 559 0.8 (0.6–1.2) 1.0 (0.8–1.2) 0.9 (0.7–1.2) 1.0 (0.8–1.4) 0.7 (0.3–1.5)
aORs, adjusted odds ratios; CIs, confidence intervals; CHD, coronary heart disease.
The numbers in boldface represent a statistically significant association.
aAdjusted for race/ethnicity, body mass index, folic acid use, gravidity, education, smoking, and parental age difference; mothers with missing 
covariate data are excluded from these analyses.
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Table 3
Estimated aORsa for a 1-year Increase in Maternal Age, National Birth Defects Prevention Study, 1997 to 
2007
Birth Defect Cases (Total No.) aOR (95% CI)
Anencephaly and craniorachischisis 377 0.99 (0.97–1.01)
Spina bifida 821 199 (0.98–1.01)
Hydrocephaly 318 0.99 (0.97–1.01)
Encephalocele 142 1.00 (0.99–1.03)
Holoprosencephaly 100 1.01 (0.97–1.04)
Dandy-Walker malformation 105 1.02 (0.98–1.06)
Anophthalmos/microphthalmos 151 1.00 (0.97–1.03)
Cataracts and other lens defects 232 1.02 (0.99–1.05)
Glaucoma and anterior segment defects 117 0.99 (0.95–1.03)
Anotia/microtia 404 1.01 (0.99–1.03)
Conotruncal defects 1651 1.02 (1.01–1.03)
 D-Transposition of the great arteries 526 1.00 (0.98–1.02)
 Double outlet right ventricular with transposition of the great arteries 101 0.98 (0.95–1.02)
Tetralogy of Fallot 750 1.04 (1.02–1.05)
Single ventricle/complex heart 218 1.01 (0.99–1.04)
Ventricular septal defects, muscular 167 1.01 (0.98–1.05)
Ventricular septal defects, perimembranous 1293 1.03 (1.02–1.04)
Ventricular septal defects, conoventricular 101 1.06 (1.03–1.10)
Atrial septal defect secundum 1493 1.01 (1.00–1.01)
Atrial septal defect, not otherwise specified 468 1.02 (1.00–1.04)
Ebstein malformation 112 1.02 (0.98–1.06)
Right ventricular outflow tract obstruction 1258 1.01 (1.00–1.03)
 Pulmonary valve stenosis 923 1.01 (1.00–1.03)
 Pulmonary atresia 159 1.00 (0.97–1.03)
 Tricuspid atresia 106 0.99 (0.96–1.03)
Left ventricular outflow tract obstruction 1359 1.01 (1.00–1.02)
 Coarctarion of the aorta 710 1.02 (1.01–1.04)
 Aortic stenosis 305 1.01 (0.99–1.04)
Hypoplastic left heart syndrome 409 1.00 (0.98–1.02)
Total anomalous pulmonary venous return 190 0.97 (0.94–1.00)
Heterotaxia with CHD 222 0.99 (0.97–1.02)
Association: coarctarion + ventricular septal defect 191 1.02 (0.99–1.05)
Association: ventricular septal defects + atrial septal defects 519 1.04 (1.03–1.06)
Association: pulmonary valve stenosis + ventricular septal defect 105 1.01 (0.98–1.05)
Association: pulmonary valve stenosis + atrial septal defect 137 1.02 (0.99–1.06)
Cleft lip ± palate 1997 1.00 (0.99–1.01)
Cleft palate 1069 1.04 (1.02–1.06)
Esophageal atresia 437 1.05 (1.03–1.07)
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Birth Defect Cases (Total No.) aOR (95% CI)
Anorectal atresia/stenosis 661 1.01 (0.99–1.02)
Intestinal atresia/stenosis 300 1.02 (0.99–1.04)
 Duodenal atresia/stenosis 142 1.05 (1.01–1.08)
Biliary atresia 120 1.00 (0.96–1.04)
Hypospadias 1466 1.05 (1.03–1.06)
Renal agenesis/hypoplasia 106 0.98 (0.94–1.02)
Limb deficiency 774 0.99 (0.98–1.00)
 Longitudinal preaxial limb deficiency 176 0.98 (0.95–1.01)
 Limb deficiency, transverse 459 1.00 (0.98–1.02)
Omphalocele 288 1.01 (0.99–1.04)
Gastroschisis 899 0.81 (0.80–0.83)
Amniotic band syndrome and limb body wall complex 219 0.93 (0.90–0.96)
Craniosynostosis 966 1.04 (1.02–1.04)
Diaphragmatic hernia 559 1.01 (0.99–1.02)
aORs, adjusted odds ratios; CIs, confidence intervals; CHD, coronary heart disease.
The numbers in boldface represent a statistically significant association.
aAdjusted for race/ethnicity, body mass index, folic acid use, gravidity, education, smoking, parental age difference; mothers with missing 
covariate data are excluded from these analyses.
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